Lung Cancer Blog

Lung cancer (Mesothelioma) is the number one cancer killer among both men and women. Lung cancer is the uncontrolled growth of abnormal cells in one or both of the lungs. Lung cancer is smoking related. However, not all smokers develop Lung cancer. Quitting smoking reduces an individual's risk significantly, although former smokers remain at greater risk for lung cancer than people who never smoked.

Saturday, May 26, 2007

A Healthy Perspective on Cancer Treatment

Representing a Healthy Perspective on Cancer Treatment

Alternative cancer treatment facility in Mesa AZ, An Oasis of Healing, launches AnOasisOfHealing.com. Thomas Lodi, MD, Homeopathic Physician and owner of An Oasis of Healing, explains the fundamental steps needed to take to naturally heal cancer.

Mesa, AZ (PRWEB) May 26, 2007 -- Thomas Lodi, MD, Homeopathic Physician and owner of An Oasis of Healing, Integrative Oncology Cancer Treatment facility in Mesa, Arizona, has just launched his new website AnOasisOfHealing.com, which provides options for alternative cancer treatment.

AnOasisofHealing.com provides you with information about the three fundamental aspects employed to treat cancer: (1) Teaching the patient to stop making cancer (2) Selectively targeting and destroying cancer without harming the person (3) Stimulating and enhancing the immune system.

Dr. Thomas Lodi also encourages those seeking a more integrative and alternative method of cancer treatment to contact the center through the website AnOasisOfHealing.com. The facility is located in downtown Mesa, Arizona and the website will provide you with further information on how to set up an appointment, what to expect during your first visit, travel information, and directions.

#_##

Press Contact: Clothilde Canale
Company Name: An Oasis of Healing
Phone: (480) 834-5414
Website:
http://anoasisofhealing.com/

Friday, May 25, 2007

Comprehensive Mesothelioma Glossary

 
LegalView.com Introduces Comprehensive Mesothelioma Glossary

LegalView.com, your resource for everything legal, has introduced a new glossary of terminology relating to the condition mesothelioma located at http://mesothelioma.legalview.com/glossary.

(PRWEB) May 25, 2007 -- LegalView.com, your resource for everything legal, has introduced a new glossary of terminology relating to the condition mesothelioma. This terminology reference is intended to add to LegalView.com's full range of Mesothelioma resources. The glossary features hundreds of legal and medical terms and exists as a compliment to the site's articles and legal information related to mesothelioma.

The glossary, located at http://mesothelioma.legalview.com/glossary, adds to the already exhaustive resources related to
mesothelioma located at LegalView.com. The glossary contains hundreds of terms and acts a companion piece to the full spectrum of mesothelioma related legal resources contained on LegalView.com's mesothelioma portal, which include articles, a mesothelioma blog, and various other bits of helpful mesothelioma legal information, as well as links providing access to mesothelioma legal advice.

Mesothelioma is a rare but fatally serious form of lung cancer that is nearly always connected to asbestos exposure. LegalView.com created its mesothelioma information portal as a free service for those looking for the latest news and information about mesothelioma and its effects, especially for mesothelioma patients and their families. This comprehensive glossary compliments the full range of articles and wide selection of links relating to mesothelioma lawsuits and mesothelioma claims, adding depth and value to the site's other legal resources. In addition to these mesothelioma legal resources, LegalView.com features a legal encyclopedia and links to helpful legal websites in each state.

LegalView.com stands on the cutting edge of approachable and useful legal content, and its new mesothelioma glossary is certainly no exception. Have questions about other legal matters? In addition to upcoming collections of legal resources related to auto accidents and practice areas for birth injuries and child injuries, LegalView.com also features extensive information on other legal issues such as automobile accidents, medical malpractice, occupational diseases and securities fraud. In addition, its attorney referral system allows parties looking for legal representation to get in touch with experienced lawyers quickly.

LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz' Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez Hodes; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.legalview.com.

##.#

Press Contact: Peter Kent
Company Name: LegalView.com
Phone: 720-771-3246
Website:
http://www.legalview.com

Monday, May 21, 2007

Advanced Technology Now Found At Cancer Center

Cancer Center Acquires Advanced Technology

NomosSTAT Encore Serial Tomotherapy System in use for 6 months at NY Cancer Center.

Rochester, NY (PRWEB) May 21, 2007 -- Dr. Charles H. Albrecht, director of Finger Lakes Radiation Oncology Center in Clifton Springs, NY announced today that the center has been using the nomosSTAT Encore Serial Tomotherapy System for 6 months. "This equipment allows us to use Intensity Modulated Radiation Therapy (IMRT) in patients with a wider variety of diseases. We have seen great improvement in side effects during treatment of pelvic malignancies and expect that these patients will have fewer long-term complications." IMRT makes it possible to precisely treat cancers which are surrounded by structures which must be protected, so that higher doses of radiation can be delivered with fewer side effects and complications. Nomos (North American Scientific) pioneered IMRT technology in the 1990s, and in 2000 Finger Lakes Radiation Oncology was the first center in the area to install the original Nomos system. The center started treating patients with the new equipment in November, 2006.

About The Finger Lakes Radiation Oncology Center
Finger Lakes Radiation Oncology Center (FLROC), founded in 1985 by Dr. Sidney Sobel, provides a radiation treatment center for patients in the Finger Lakes area. The FLROC is attached to both the Clifton Springs Hospital & Clinic (CSH&C) and The Springs, allowing our patients convenient access to additional services and providers. FLROC has technology comparable and in some cases better than technology available in large centers and our treatment planning is more sophisticated and elegant than is common elsewhere. We also offer brachytherapy services including prostate seed implants, gynecologic implants, and Iodine therapy for thyroid cancer and hyperthyroidism. Please Visit our Web site at: www.flrocenter.com.

#+##

Press Contact: Dr. Charles H. Albrecht, M.D.
Company Name: Finger Lakes Radiation Oncology Center
Phone: (315) 462-5711
Website:
http://www.flrocenter.com/

Saturday, May 12, 2007

Mesothelioma-Search-Engine.com - Onconase as Chemopreventive Agent in Mesothelioma

Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting

BLOOMFIELD, N.J., April 18, 2007 /PRNewswire-FirstCall/ -- ONCONASE (ranpirnase), Alfacell Corporation's lead drug candidate, may have potential as a chemopreventive agent, according to world-renowned mesothelioma researcher Michele Carbone M.D., Ph.D., at this week's American Association for Cancer Research (AACR) Annual Meeting.

In a series of poster presentations, Dr. Carbone highlighted the growing worldwide problem of asbestos exposure and its link to malignant mesothelioma. Dr. Carbone presented data that show the early detection in patients at high risk for developing malignant mesothelioma is becoming more prevalent via the presence of certain biological markers in blood samples. Furthermore, he pointed out that ONCONASE's favorable toxicity profile and its well-documented mechanism of action, which directly affects the pathway that has been shown to cause asbestos carcinogenesis, position ONCONASE for potential early administration to populations "at-risk" for mesothelioma. If clinically validated, such a new approach might enable physicians to use ONCONASE as a chemopreventive agent to potentially prevent the onset of mesothelioma, or reduce the doses of cytotoxic agents needed in those patients who develop the disease.

"The potential of ONCONASE as an early first-line preventative treatment for mesothelioma is an exciting development that we plan to investigate through clinical trials," said Dr. Carbone. "With approximately more than 25 million asbestos exposure cases reported worldwide, we believe that ONCONASE might play a greater role in the treatment protocols for a much larger population than was originally envisioned for this dismal disease."

Dr. Carbone is a professor and director of the thoracic oncology program as well as a clinical professor of pathology with the University of Hawaii's Cancer Research Center of Hawaii, and chairman of the Alfacell Thoracic Advisory Board. Previously, Dr. Carbone was Director of the Thoracic Oncology Program at Loyola University in Chicago, where he is also a tenured Professor at the Cancer Center, Department of Pathology. He also held scientific and academic positions at the National Institutes of Health (NIH), and at the University of Chicago.

Kuslima Shogen, Alfacell's chairman and chief executive officer, added: "Dr. Carbone is recognized as one of the world's leading researchers in mesothelioma. His remarks about ONCONASE at the AACR Annual Meeting reflect the interest of the international medical community in expanding the potential uses of ONCONASE."

About ONCONASE(R)

ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. ONCONASE triggers apoptosis, the natural death of cells, via multiple molecular mechanisms of action.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors. For more information, visit www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    Media Contact:                      Investor Contact:
    David Schull or Wendy Lau          Andreas Marathovouniotis
    Noonan Russo                        Noonan Russo
    212-845-4271                        212-845-4253
            
david.schull@eurorscg.com andreas.marathis@eurorscg.com wendy.lau1@eurorscg.com

CONTACT: David Schull or Wendy Lau, +1-212-845-4271, or, or , or AndreasMarathovouniotis, +1-212-845-4253, or , all ofNoonan Russo david.schull@eurorscg.com wendy.lau1@eurorscg.com andreas.marathis@eurorscg.com

Web site:
http://www.alfacell.com/http://www.noonanrusso.com/

Thursday, May 10, 2007

Preventive Measures, Detoxification, and Supplementation Keys to Better Health

Expert Physician, Author Shines Light on Preventive Measures and Promotes Regular Detoxification and Ongoing Supplementation as Keys to Better Health

Leading physician and author of best-selling medical books partners with Detoxologie.com to heighten awareness of need for ongoing cleansing program as part of an overall preventative health plan.

Englewood, CO (PRWEB) May 10, 2007 -- Hyla Cass M.D., an expert in integrative medicine who has authored several books, including Natural Highs and 8 Weeks to Vibrant Health, has partnered with Detoxologie.com to draw attention to the positive benefits of preventive health care, including internal cleansing.

"As a practicing physician, experience has taught me that prevention is the best method for health maintenance," Dr. Cass explains. "Since the digestive system is the first entryway for many toxins and pathogens (such as bacteria and parasites), regular detoxification is a requirement for optimal health. I have found Detoxologie™ to be one of the most comprehensive and effective colon cleansing programs available."

Dr. Cass, a nationally acclaimed innovator and expert in the field of integrative medicine, combines the best of leading-edge natural medicine with modern science in her clinical practice, writings, lectures and nationwide media appearances, most recently on ABC's top-rated daytime show The View.

As Dr. Cass stresses, detoxification is a normal, natural, and necessary part of daily well-being and health maintenance. Because of this, detoxification should be done on a consistent basis, and supported by ongoing efforts through diet and supplementation, using such products as Detoxologie's™ high-potency 30-Day Body-Cleansing and Renewal Program.

A member of the Medical Advisory Board of the Health Sciences Institute and Taste for Life magazine, and an Associate Editor at Total Health Magazine, Dr. Cass supports detoxification because once the body is cleansed and functioning more efficiently, it will absorb more nutrients from foods, allowing users to finally side-step destructive cravings for "bad" carbohydrates and saturated fats.

"It's a win-win situation," explains Detoxologie™ owner Steve Franzmann, who has suffered four strokes, the first at the age of 35. After years of extensive evaluation, Steve's medical condition was diagnosed as Lupus Anti-Coagulation Syndrome, a genetic blood disorder. During this time, rather than take multiple prescription medications that only seemed to make matters worse, Steve and wife Kelley teamed up with master herbalist Bob Nikkel in search of a natural alternative. The remarkable improvement in Steve's health led to the creation of the Detoxologie™ product line, which safely and quickly eliminates toxins from not only the digestive tract, but the organs and very cells themselves, providing Steve and other users alike with a more solid foundation on which to build better health.

In repairing Steve's health and helping others do the same, the Franzmann's have consulted with some of the nation's foremost experts on integrative medicine and naturopathic treatments. Their research and findings on the importance of internal cleansing and detoxification has led to ongoing improvements in Steve's personal health. This remains the driving force behind their commitment to providing education and a product line that will help others find health as well, an unwavering commitment they share with Dr. Cass.

About Detoxologie™ (http://www.detoxologie.com)
Detoxologie™ is a subsidiary of Triesca International LLC. Detoxologie™ is dedicated to providing safe and effective products to cleanse and detoxify the body. By offering the most comprehensive and effective herbal supplements, focusing primarily on "whole-body" detoxification and backing it up with a no questions asked-100% money back guarantee, Detoxologie™ aims to become the leading online retailer of internal cleaning products.

Media Contact:
Kelley Franzmann
triesca @ gmail.com

## - #

Press Contact: KELLIE FOWLER
Company Name: Detoxologie
Phone: 613-326-0563
Website:
http://www.detoxologie.com

Saturday, May 05, 2007

Source Of Tension Headaches Targeted

Redesigned Therapeutic Aid Takes Aim At The Source Of Tension Headaches

A new design of The Relief Pyramid, the time-tested device for relief of tension headache and underlying stress, is now available online. Designed by an Osteopathic Physician with specialty training in manipulative medicine, The Relief Pyramid targets suboccipital muscle tightness, a frequent cause of common headaches. Effective, portable and inexpensive, it is a promising and powerful tool for millions worldwide who are suffering from chronic headaches.

Tucson, Arizona (PRWEB) May 5, 2007 -- A new design of The Relief Pyramid, the time-tested device for relief of tension headache and underlying stress, is now available online. Designed by an Osteopathic Physician with specialty training in manipulative medicine, The Relief Pyramid targets suboccipital muscle tightness, a frequent cause of common headaches. Effective, portable and inexpensive, it is a promising and powerful tool for millions worldwide who are suffering from chronic headaches.

The most common type of headache is the tension headache. Studies indicate between 63%-93% of men and women over the age of 25 experience tension headache. In today's fast-paced and time-starved world, a common cause of headache is that of stress and tightness/spasm of the suboccipital muscles (found in the upper neck just below the bony skull). While analgesics and different forms of therapy may temporarily alleviate symptoms, headaches often reoccur.

With the availability of The Relief Pyramid headache reducing device, sufferers now have another option -- a drug-free, safe and effective aid that can be used anytime, in the comfort of home or office. Originally, the device was a one-piece monolithic foam product available in two sizes, short and tall. The new and improved Relief Pyramid is now a two-piece adjustable unit, incorporating a reversible top pad. This simple enhancement allows for customization of The Relief Pyramid height to accommodate different patient sizes.

While the latest iteration of the device has only recently been made available, the basic concept behind The Relief Pyramid is not new. Archaeologists have found beds used by the Ancient Egyptians that raised the head during sleep, decompressing the skull (or occiput) from the upper vertebrae of the neck (atlas of the cervical spine). There is evidence that Orientals used similar devices thousands of years ago. More recently, Dr. Andrew Taylor Still, the founder of Osteopathic Medicine, fashioned his own version of this bed-like device that he called the Saints Rest.

The idea behind all of these designs involves the principle of occipital decompression. Unfortunately, devices for nighttime use involve spending extended periods of sleep in the same position. Another relatively recent adaptation of the occipital decompression idea, though impractical for many people nowadays, was Dr. Still's "rope tied between two trees." Yet, the desired objective of all these devices is the same: decrease suboccipital muscle tightness, gently stretch the dural tube and realign the occiput on the atlas to relieve tension headache.

What is new with the advent of The Relief Pyramid is a comfortable, portable and affordable design. Three gentle therapies occur during the same 10-20 minute relaxation session. The first is muscle inhibition, where a gentle inhibitory pressure is applied to tight suboccipital muscles to reduce spasm. Second is occipital decompression, where the skull is lifted out of and released from its impacted position. The third is a gentle craniosacral technique (CV-IV) that resets the body's cerebrospinal mechanism thereby reducing stress and inducing a feeling of well-being. All three techniques are specifically addressed by The Relief Pyramid design: the bowl-shaped edge, adjustable height and foam pad resiliency.

Over 15 years of design, testing and refinement have gone into the development of The Relief Pyramid. During his post-graduate Osteopathic training, inventor Richard Brown, D.O. (now retired) recognized the need for a specially designed therapeutic aid he could recommend to patients. Prior, practitioners would often advise use of a padded stack of books or a tennis ball to target tight suboccipital muscles. In an effort to make a specific product available to all, he began experimenting with designs in 1990.

The arrival of The Relief Pyramid to the marketplace is the result of many years research into design and materials. Marketed exclusively by TheraProducts, Inc. (an Arizona Corporation), purchase of The Relief Pyramid and further in-depth details are available on the Web at www.reliefpyramid.com

Contact:
TheraProducts, Inc.
info @ reliefpyramid.com
Tel. (520) 498-2292
www.reliefpyramid.com

Copyright © 2007 TheraProducts, Inc
All Rights Reserved

## ( #

Press Contact: Richard Brown
Company Name: TheraProducts, Inc.
Phone: 520-498-2292
Website:
www.reliefpyramid.com